格隆汇1月8日丨棕榈股份(002431.SZ)公布，收到公司控股股东告知，根据河南省人民政府的相关安 排，公司实际控制人河南省财政厅将持有的中原豫资投资控股集团有限公司（简称"豫资集团"）100% 股权无偿划转至河南省人民政府国有资产监督管理委员会（简称"河南省国资委"），经查询国家企业信 用信息公示系统，相关变更手续已于2026年1月5日核准完成。由于豫资集团持有公司控股股东河南省豫 资保障房管理运营有限公司100%股权，是公司的间接控股股东。此次间接控股股东股权的无偿划转， 将导致公司实际控制人由河南省财政厅变更为河南省国资委。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002676 证券简称：顺威股份 公告编号：2025-062 广东顺威精密塑料股份有限公司 关于间接控股股东股权结构变动暨公司实际控制人发生变更的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 重要提示： 1. 本次实际控制人变更系广东顺威精密塑料股份有限公司（以下简称"公司"）间接控股股东广州开发区 投资集团有限公司（以下简称"开投集团"）的股东和出资人由广州开发区国有资产监督管理局（以下简 称"广州开发区国资局"）变更为广州经济技术开发区管理委员会（以下简称"广州开发区管委会"）所 致。 2. 本次实际控制人变更后，公司的实际控制人由广州开发区国资局变更为广州开发区管委会。广州开发 区国资局是广州开发区管委会的下属机构。 3. 本次实际控制人变更系公司间接控股股东开投集团的股权结构变动导致，不触及要约收购，不涉及公 司控股股东广州开投智造产业投资集团有限公司（以下简称"智造公司（原智造产投）"）所持公司股份 数量及持股比例的变动，公司控股股东仍为智造公司。 一、本次间接控股股东股权结构变动暨 ...

顺威股份公告，公司间接控股股东广州开发区投资集团有限公司的股东和出资人由广州开发区国有资产 监督管理局变更为广州经济技术开发区管理委员会，导致公司实际控制人由广州开发区国资局变更为广 州开发区管委会。广州开发区国资局是广州开发区管委会的下属机构。本次实际控制人变更不触及要约 收购，不会导致公司控股股东发生变更，公司控股股东仍为广州开投智造产业投资集团有限公司。 ...

Core Viewpoint - The equity change involves the transfer of a total of 43,233,875 shares (9.85% of total shares) from three parties to Langning Yihe, leading to a change in control of the company [1] Group 1: Equity Transfer Details - Qinhai Yifeng Technology Investment Co., Ltd., Li Songqiang, and Wang Feng transferred their shares to Langning Yihe, with Wang Feng also entrusting voting rights of an additional 9,874,125 shares [1] - Langning Yihe, through acquiring 70% of Yifeng Technology, gains control over Qinhai Heavy Machinery, which allows it to exercise voting rights corresponding to 4.11% of the company's shares [1] - After the dissolution of the "Joint Action Agreement" between Wang Feng and Yu Shiguang, both parties will no longer act in concert regarding company decisions [1] Group 2: Control and Management Changes - Following the equity transfer, the controlling shareholder shifts from Qinhai Heavy Machinery to Langning Yihe, with the actual controllers being Zhu Jiayang, Zhan Shundi, and Zhang Dong [2] - Langning Yihe's operational management is handled by Langning Energy, which is fully owned by Zhu Jiayang, Zhan Shundi, and Zhang Dong [2] Group 3: Financial Aspects of the Acquisition - The cash consideration for the acquisition amounts to 349.5719 million yuan, with 300.26 million yuan already received, funded by the partners [3] - The actual controllers contributed 240.26 million yuan from their own funds, while a partner contributed 60 million yuan, with the remaining amount to be funded by Langning Yihe [3]

Core Viewpoint - Dongjie Intelligent's stock experienced significant volatility following the announcement of a potential change in its actual controller, with a notable increase in stock price prior to the suspension of trading [1][2]. Group 1: Stock Performance - Dongjie Intelligent's stock opened at 27.18 yuan, rising by 18.02% upon resumption of trading, but closed at 23.18 yuan, reflecting a modest increase of 0.65% [1]. - Prior to the trading suspension, the stock had surged over 180%, with three consecutive trading days of 20% limit-up [1]. Group 2: Shareholding Changes - On August 25, 2025, a transfer agreement was signed where the controlling shareholder's upper-level equity structure is set to change, with the transfer of 99% of the fund shares from Zibo Financial Holdings Group to Hainan Heping Investment for 1.62 billion yuan [2]. - The controlling shareholder, Zibo Jiangtu, will retain the same number of shares, holding 119,659,940 shares, which represents 26.25% of the total share capital [2]. Group 3: Impact on Company Structure - The equity change does not involve a takeover bid or related transactions and will not affect the company's business structure, financial status, or operational independence [3].

Core Points - The company has undergone a change in its actual controller, with a 2% equity transfer from Chongqing Chemical Medicine Holdings to China General Technology Group [5][6][7][8] - The company has approved a share repurchase plan during the board meeting held on July 10, 2025, which was subsequently ratified by the shareholders [8][10] - The company has also reported the release of pledged shares by its controlling shareholder, involving 109,867,400 shares [8][9] Company Overview - The company is identified as Chongqing Pharmaceutical Holdings, with the stock code 000950 [1] - The board of directors has confirmed that all members attended the meeting to review the report [2] - The company has not proposed any cash dividends or stock bonuses for the reporting period [3] Financial and Operational Highlights - The company has not experienced any changes in its controlling shareholder during the reporting period [5] - The company has completed the necessary registration procedures for the equity transfer related to the change in actual controller [7] - The board has approved the 2025 semi-annual report and its summary [24][25]